Literature DB >> 15070952

Adiponectin in anorexia nervosa and bulimia nervosa.

Tetsuya Tagami1, Noriko Satoh, Takeshi Usui, Kazunori Yamada, Akira Shimatsu, Hideshi Kuzuya.   

Abstract

To study the role of adiponectin, a novel adipocyte-specific secreted protein, on the pathophysiology of eating disorders, circulating levels of fasting adiponectin, leptin, insulin, and glucose were measured in 31 female patients with anorexia nervosa (AN) and in 11 with bulimia nervosa. Hormone levels were compared with 16 age-matched, normal body weight controls, six healthy constitutionally thin subjects, and nine obese subjects. Moreover, changes in levels were reevaluated after nutritional treatment and weight gain in 13 patients with AN. Serum adiponectin concentrations in AN and bulimia nervosa were significantly lower than those in normal-weight controls. These results were unexpected because the levels were high in constitutionally thin subjects and low in obese subjects, which provide a negative correlation with body mass index (BMI) and body fat mass. In contrast, serum leptin levels correlated very well with BMI and fat mass among all the patients and controls. The insulin resistance was significantly low in AN and high in obese subjects. The concentrations of adiponectin after weight recovery increased to the normal level despite a relatively small increase in BMI. These findings suggest that abnormal feeding behavior in the patients with eating disorders may reduce circulating adiponectin level, and weight recovery can restore it.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15070952     DOI: 10.1210/jc.2003-031260

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  43 in total

Review 1.  Body composition and skeletal health: too heavy? Too thin?

Authors:  Alexander Faje; Anne Klibanski
Journal:  Curr Osteoporos Rep       Date:  2012-09       Impact factor: 5.096

2.  Altered metabolism and lipodystrophy in the early B-cell factor 1-deficient mouse.

Authors:  Jackie A Fretz; Tracy Nelson; Yougen Xi; Douglas J Adams; Clifford J Rosen; Mark C Horowitz
Journal:  Endocrinology       Date:  2010-02-19       Impact factor: 4.736

Review 3.  The neuroendocrine basis of anorexia nervosa and its impact on bone metabolism.

Authors:  Madhusmita Misra; Anne Klibanski
Journal:  Neuroendocrinology       Date:  2011-01-13       Impact factor: 4.914

Review 4.  The endocrine manifestations of anorexia nervosa: mechanisms and management.

Authors:  Melanie Schorr; Karen K Miller
Journal:  Nat Rev Endocrinol       Date:  2016-11-04       Impact factor: 43.330

5.  Differential effects of energy balance on experimentally-induced colitis.

Authors:  Sarah J McCaskey; Elizabeth A Rondini; Ingeborg M Langohr; Jenifer I Fenton
Journal:  World J Gastroenterol       Date:  2012-02-21       Impact factor: 5.742

Review 6.  Endocrine consequences of anorexia nervosa.

Authors:  Madhusmita Misra; Anne Klibanski
Journal:  Lancet Diabetes Endocrinol       Date:  2014-04-02       Impact factor: 32.069

7.  Susceptibility loci for adiposity phenotypes on 8p, 9p, and 16q in American Samoa and Samoa.

Authors:  Karolina Aberg; Feng Dai; Guangyun Sun; Ember D Keighley; Subba R Indugula; Sarah T Roberts; Qi Zhang; Diane Smelser; Satupaitea Viali; John Tuitele; Li Jin; Ranjan Deka; Daniel E Weeks; Stephen T McGarvey
Journal:  Obesity (Silver Spring)       Date:  2008-12-18       Impact factor: 5.002

Review 8.  Neuroendocrine consequences of anorexia nervosa in adolescents.

Authors:  Madhusmita Misra; Anne Klibanski
Journal:  Endocr Dev       Date:  2009-11-24

9.  Adiposity-related biochemical phenotype in senescence-accelerated mouse prone 6 (SAMP6).

Authors:  Kimie Niimi; Eiki Takahashi; Chitoshi Itakura
Journal:  Comp Med       Date:  2009-10       Impact factor: 0.982

10.  Insulin-like Growth Factor 1 and Adiponectin and Associations with Muscle Deficits, Disease Characteristics, and Treatments in Rheumatoid Arthritis.

Authors:  Joshua F Baker; Joan Marie Von Feldt; Sogol Mostoufi-Moab; Woojin Kim; Elena Taratuta; Mary B Leonard
Journal:  J Rheumatol       Date:  2015-09-01       Impact factor: 4.666

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.